Navana Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '24 Mar 31, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Revenue	6,504	5,706	4,759	3,607	3,149
Revenue Growth (YoY)	22.00%	19.91%	31.95%	14.53%	-
Cost of Revenue	3,511	3,110	2,599	1,993	1,740
Gross Profit	2,993	2,596	2,160	1,614	1,409
Selling, General & Admin	2,127	1,875	1,591	1,265	1,135
Operating Expenses	2,127	1,875	1,591	1,265	1,135
Operating Income	865.75	721.47	569.6	348.59	274.18
Interest Expense	-293.38	-234.89	-200.42	-75.18	-91.59
Interest & Investment Income	1.66	5.84	5.58	0.03	0.04
Currency Exchange Gain (Loss)	-36.77	-33.38	-93.98	-2.52	-5.11
Other Non Operating Income (Expenses)	27.05	32.34	27.64	30.47	22.09
EBT Excluding Unusual Items	564.31	491.38	308.42	301.39	199.6
Gain (Loss) on Sale of Investments	0.97	-42.3	82.9	-	19.68
Gain (Loss) on Sale of Assets	1.46	-	0.47	1.02	-
Pretax Income	566.74	449.08	391.79	302.41	219.28
Income Tax Expense	126.73	92.14	117.78	100.12	81.88
Net Income	440.01	356.94	274	202.29	137.4
Net Income to Common	440.01	356.94	274	202.29	137.4
Net Income Growth	33.05%	30.27%	35.45%	47.23%	-
Shares Outstanding (Basic)	108	99	80	80	80
Shares Outstanding (Diluted)	108	99	80	80	80
Shares Change (YoY)	16.28%	23.91%	-	-	-
EPS (Basic)	4.09	3.59	3.42	2.52	1.71
EPS (Diluted)	4.09	3.59	3.42	2.52	1.71
EPS Growth	14.43%	5.13%	35.45%	47.23%	-
Free Cash Flow	-838.44	-1,404	-1,160	-399	181.8
Free Cash Flow Per Share	-7.80	-14.13	-14.45	-4.97	2.27
Dividend Per Share	1.300	1.300	1.100	-	-
Dividend Growth	18.18%	18.18%	-	-	-
Gross Margin	46.02%	45.50%	45.39%	44.74%	44.73%
Operating Margin	13.31%	12.64%	11.97%	9.67%	8.71%
Profit Margin	6.77%	6.26%	5.76%	5.61%	4.36%
Free Cash Flow Margin	-12.89%	-24.61%	-24.37%	-11.06%	5.77%
EBITDA	1,023	882.18	675.37	397.71	314.49
EBITDA Margin	15.72%	15.46%	14.19%	11.03%	9.99%
D&A For EBITDA	156.93	160.7	105.77	49.12	40.31
EBIT	865.75	721.47	569.6	348.59	274.18
EBIT Margin	13.31%	12.64%	11.97%	9.67%	8.71%
Effective Tax Rate	22.36%	20.52%	30.06%	33.11%	37.34%
Advertising Expenses	-	33.13	80.86	19.55	16.63

Source: S&P Capital IQ. Standard template. Financial Sources.